About Argenica Therapeutics

Argenica Therapeutics is a developing novel neuroprotective therapeutics to reduce brain damage after stroke.

Company Highlights
Year Founded

2019

icon-altEmployees

6

Location (HQ)

AUS

Since Last Funding

1 year 7 months

Monthly Website Visitors

1.3K

icon-altTotal Investment Amt

$800K

Last Funding Round

Grant

icon-altYoY Headcount Growth

-14.08%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceuticals

Pharmaceutical Manufacturing